A growing body of evidence indicates that a neuropathological cross-talk takes place
between the coronavirus disease 2019 (COVID-19)-the pandemic severe pneumonia that …

Parkinson's disease (PD) is a neurodegenerative disease characterized by the
degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNpc) and …

The 2019 novel coronavirus disease (COVID-19) is an infectious disease that began to
spread globally since 2019. Some COVID-19 patients have neurological complications …

Post-acute neurological sequelae of COVID-19 affect millions of people worldwide, yet little
data is available to guide treatment strategies for the most common symptoms. We …

Abstract Purpose of Review Research has shown myriad neurologic and mental health
manifestations during the acute and subsequent stages of COVID-19 in people with HIV …

COVID-19 is an ongoing global pandemic caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) virus. Although it primarily attacks the respiratory tract …

Background Little is known about the impact of the COVID-19 pandemic on patients with
Parkinson's disease (PD) at different stages of the pandemic. This study aims to assess the …

The long COVID (coronavirus disease), a multisystemic condition following severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, is one of the widespread …

COVID-19 patients often display dysfunctions of the nervous system, indicating an effect of
SARS-CoV-2 on neural cells. Yang et al. now show that human stem-cell-derived …

Choroid plexus insufficiency or glymphatic stasis are often classified as prequels to harmful
accretion of toxic proteins in neurodegenerative disease. Cognitive decline and disordered …